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1. Introduction 
Diabetes mellitus is a metabolic disorder, suffered by hundreds of millions of people 
throughout the world, which is characterized by hyperglycemia resulting from 
insufficiency of insulin secretion and/or action (Wild et al., 2004). Complications 
associated with diabetes affecting vessels, eyes, kidney, and peripheral nerves reduce the 
QOL of diabetic patients. Also, diabetes is widely recognized as a major risk factor for 
atherosclerotic disease such as acute brain ischemia. Indeed, diabetic patients have a 
higher risk of stroke compared with non-diabetic patients (Baynes 1991; Stephens et al., 
2009). Additionally, they are more likely to have a poor prognosis and increased mortality 
after stroke (Biller et al., 1993; Vinik et al., 2002). Previous studies have demonstrated that 
the diabetic state increases oxidative stress in the brain and aggravates cerebral ischemic 
injury in both type I (Li et al., 2004; Saito et al., 2005; Rizk et al., 2005) and type II diabetic 
animal models (Anabela et al., 2006; Tureyen et al., 2011). In addition to neuronal damage 
attributed to hypoxia and ATP depletion caused by vascular obstruction in ischemic core 
region, cerebral injury caused by subsequent reperfusion is also involved in the 
pathophysiology of transient ischemia (Doyle et al., 2008; Nakka et al., 2008; Wang et al., 
2010). During reperfusion, the production of reactive oxygen species (ROS) and reactive 
nitrogen species (RNS) is enhanced by abrupt re-oxygenation (Cuzzocrea et al., 2001; Saito 
et al., 2005). Besides direct injurious effects to the cell membrane, proteins and DNA by 
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oxidation, ROS and RNS activate the pro-apoptotic pathway including the activation of 
caspase family proteases leading to DNA fragmentation in the neuronal cells of the 
ischemic penumbral region (Sugawara et al., 2007; Nakka et al., 2008). Hyperglycemia is 
assumed to be a major factor responsible for excessive generation of ROS. In the diabetic 
state, “glucose toxicity” caused by augmentation of the intracellular glucose oxidation 
process and non-enzymatic glycation of protein molecules leads to over production of 
ROS (Baynes, 1991; Giacco et al., 2010). Moreover, experimental transient hyperglycemia 
caused by intravenous infusion of glucose has been shown to increase ROS production 
and exacerbate brain injury after ischemia and subsequent reperfusion in rats (Tsuruta et 
al., 2010).  
In addition to apoptotic cell death, inflammatory neurodegeneration is a crucial process 
contributing to cerebral damage after ischemia and reperfusion (Brown et al., 2010). ROS has 
been shown to activate nuclear factor-B (NF-B), which enhances transcription of the genes 
encoding pro-inflammatory cytokines and cell adhesion molecules, leading to 
neuroinflammatory responses (Saeed et al., 2007). Activation of the transcription factor NF-
B by ROS in microglia and astrocytes leads to an increase in the expression of 
cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS) and pro-inflammatory 
cytokines including TNF-, IL-1 and IL-6, which accelerate inflammatory responses and 
promote neuronal cell death in the ischemic region (Brown et al., 2010). Gene expression of 
IL-1and IL-6 is much higher in type2-diabetic mice as compared with normoglycemic 
control mice (Tureyen et al., 2011). These pro-inflammatory cytokines and inflammatory 
mediators have been indicated to induce further inflammatory responses involving 
extravasation of neutrophils, macrophages/microglia through the expression of intracellular 
adhesion molecule 1 (ICAM-1) in endothelial cells (Wang et al., 2002; Chrissobolis et al., 
2011). Myeloperoxidase (MPO) expressing in neutrophils and macrophages/ microglia, 
which has often been used as a histopathological marker for inflammation, generates ROS 
such as hypochloride and super oxide anion radical (O2⁻·) and leads to further tissue 
damage (Breckwoldt et al., 2008). Thus, enhanced oxidative stress and inflammatory 
responses induced by hyperglycemia may substantially contribute to the exacerbation of 
cerebral injury caused by transient ischemia and subsequent reperfusion in the diabetic 
state. 
Ganoderma lucidum (G. lucidum), a very popular medicinal fungus, has long been known 
for its beneficial effects on human health and longevity in Asian countries. Its fruiting 
bodies and cultured mycelia are used to treat chronic hepatopathy (Shi et al., 2008), 
hypertension (Kabir et al., 1988), hyperglycemia (Zhang et al., 2004), and tumor (Lu et al., 
2003; Kubo et al., 2005). The pharmacological activities of G. lucidum constituents 
responsible for many of its health benefits, such as antioxidant (Zhu et al., 1999), 
anticancer (Lu et al., 2003; Kubo et al., 2005), anti-inflammatory (Akihisa et al., 2007), and 
immunomodulatory activities (Lai et al., 2010) have been elucidated. The water-soluble 
extract from culture medium of G. lucidum mycelia (MAK), a commercially available 
nutritional supplement, is a freeze-dried powder of a hot-water extract prepared from a 
solid culture medium composed of bagasse and defatted-rice bran overgrown with  
G. lucidum mycelia by cultivation for about 3.5 months. In a previous study, we 
demonstrated that the orally administered MAK attenuated oxidative stress and relieved 
exacerbation of cerebral injury induced by middle cerebral artery occlusion and 
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reperfusion (MCAO/Re) in streptozotocin (STZ)-induced diabetic rats (Iwata et al., 2008). 
However, the mechanism of its cerebroprotective effect still remains unclear. Thus, we 
evaluated the effects of chronic oral pretreatment of MAK on the production of O2⁻· and 
apoptosis in STZ-rat brain after MCAO/Re. Furthermore, to clarify whether MAK 
suppresses inflammatory responses induced by the transient ischemia and reperfusion, 
we examined the effects of MAK on the expression profile of TNF-, IL-1, iNOS, COX-2, 
ICAM-1 and MPO in the brain during reperfusion. 
2. Materials and methods 
2.1 Experimental diabetic animals 
Male Sprague Dawley rats (4-week old, weight 120-140 g; Tokyo Exp. Animal Co., Ltd., 
Tokyo, Japan) were purchased and housed in a temperature-controlled environment (23 ± 
0.5°C) with a cycle of 12 hrs light and 12 hrs dark. The rats were given a standard rodent 
chow and water ad libitum. Animal care and the surgical procedure were performed in 
accordance with guidelines approved by the National Institutes of Health and the Josai 
University Animal Investigation Committee. A diabetic state was induced in the rats 
(diabetic group) by a single injection of STZ (60 mg/kg, i.p.) dissolved in 0.1 mM sodium 
citrate (pH 4.5), while the rats of the non-diabetic group were injected with buffer only 
(Iwata et al., 2008). Seven days after the STZ-injection, the plasma glucose level was 
determined using a glucose analyzer (Ascensia, Bayer Medical Co., Ltd., Land Nordrhein-
Westfalen, Germany). Diabetes was defined by a blood glucose level greater than 300 
mg/dl. Then, the diabetic and non-diabetic groups were divided into two groups 
respectively and were housed for an additional 6 weeks until stroke was induced by MCAO. 
MAK (1 g/kg; MAK group) or distilled water (control group) was administrated orally once 
daily for the last 2 weeks. 
2.2 Middle cerebral artery occlusion and reperfusion 
Focal cerebral ischemia was induced by MCAO with a standard intraluminal filament 
technique as previously described (Iwata et al., 2010). The animals were anesthetized with 
4% halothane and maintained with 1.5% halothane and 30% oxygen under spontaneous 
respiration. After a midline incision at the neck, the right common carotid artery was 
exfoliated under an operating microscope. All branches of the external carotid artery were 
isolated and ligated. The tip of the 4-0 surgical nylon monofilament rounded by flame 
heating was inserted up through the internal carotid artery. When a small resistance was 
felt, insertion was stopped. The distance from bifurcation of the common carotid artery to 
the tip of the suture was approximately 20 mm in all rats. Cerebral blood flow was detected 
by laser Doppler Flowmetry (ATBF-LC1, Unique Medical Co., LTD., Tokyo) and about 50% 
reduction of its baseline associated with MCAO was ascertained in the rats. Rectal 
temperature was maintained at 37°C with a heat lamp and a heating pad during the 
operation. After 2 hrs of occlusion, the filament was withdrawn to allow for reperfusion. 
Then, the animals were permitted to recover from the anesthesia at room temperature. The 
rats were reperfused for 3 or 24 hrs before they were killed. The sham operation with the 
same manipulation without introduction of the monofilament was also performed in the 4 
rats of the non-diabetic and diabetic groups, respectively. 
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2.3 Neurological evaluation 
Post-ischemic neurological deficits were evaluated after 3 or 24 hrs of reperfusion on a 5-
point scale as described as follows: grade 0:no deficit, grade 1:failure to extend right 
forepaw fully, grade 2:spontaneous circling or walking to contralateral side, grade 3:walking 
only when stimulated, grade 4:unresponsive to stimulation and a depressed level of 
consciousness, grade 5:death (Iwata et al., 2008; Vinik et al., 2002). Animals that did not 
show neurological deficits were excluded from the study. 
2.4 Infarct and edema assessment 
After 3 or 24 hrs of reperfusion, the animals were deeply anesthetized with diethyl ether and 
decapitated. The brain was removed and cut into four 2-mm coronal sections using a rat 
brain matrix, and stained with 2% 2,3,5-triphenyltetrazolium chloride (TTC; Wako Pure 
Chemicals) at 37°C for 15 min. The coronal slices were fixed in 10% formaldehyde for 
photography (Iwata et al., 2008; Vinik et al., 2002). Then, infarct areas were determined by 
using the image analysis system (Scion Image 1.62), and were added to obtain the infarct 
volumes per brain. Corrected infarct volume (%) = [left hemisphere volume - (right 
hemisphere volume - the infarct volume)] / left hemisphere volume × 100. Edema in the 
ischemic hemisphere was also calculated: edema (%) = (right hemisphere volume - the 
infarct volume) / left hemisphere volume. 
2.5 Detection of O2-· generation in brain  
Detection of intracellular O2-· generation in the penumbral region of the cortex following 
MCAO/Re was performed by staining freshly frozen brain sections (8 m thick) with the 
fluorescent probe dihydroethidium (DHE). The brain sections were immediately incubated 
with DHE (10 mol/l, Sigma) in phosphate-buffered saline for 30 min at 37°C (Muranyi et 
al., 2006). To determine the fluorescent intensity of oxidized DHE, three microscopic fields 
at the penumbral cortex regions of each hemisphere were captured using a confocal laser-
scanning microscope at excitation of 510 nm and emission of 580 nm. Fluorescence intensity 
of the oxidized DHE was quantified using imaging software (FV10-ASW 1.7, OLYMPUS Co. 
Ltd., Tokyo, Japan). 
2.6 TUNEL staining 
Apoptosis in the brain tissues was measured using the Apoptosis in situ Detection Kit Wako 
(Wako, Laboratories, Osaka, Japan), which is based on the TUNEL (Terminal 
deoxynucleotidyl Transferase (TdT)-mediated dUTP nick end labeling) procedure, that is 
the addition of fluorescein-dUTP to 3’-terminals of apoptotically fragmented DNA with TdT 
followed by immunochemical detection using anti-fluorescein antibody conjugated with 
horseradish peroxidase (POD) and DAB (3-3’-diaminobenzidine tetrachloride) as a 
substrate. Coronal brain sections (8 m thick) were used for the assay. The slides were 
lightly counterstained with hematoxylin and observed under a microscope (BX51W1, 
OLYMPUS). Quantification of TUNEL positive cells was achieved by cell counting in areas 
of the penumbral cortex affected by ischemia. Three randomly chosen visual fields were 
counted in each region by an investigator without knowledge of the experimental 
conditions. The percentage of apoptotic cells was calculated by the apoptotic index, i.e. 
dividing the number of positive-staining nuclei by the total number of nuclei (Li et al., 2004). 
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2.7 Real-time PCR analysis 
The temporal gene expression patterns of pro-inflammatory cytokines (IL-1 and TNF-) 
and inflammatory mediators (COX-2, iNOS and ICAM-1) were evaluated by quantitative 
real-time PCR analysis as described earlier (Liu et al. 2007). The rats subjected to MCAO 
were killed at 3 or 24 hrs of reperfusion, and the total RNA sample was obtained from the 
ischemic penumbral cortex of each rat. Total RNA was extracted with RNeasy Mini Kit 
(QIAGEN, Hilden, Germany) according to the manufacturer’s instructions. Total RNA (0.5 
g) from each sample was reverse-transcribed with oligo dT and random hexamer primers 
using reverse transcriptase (PrimeScriptTM RT Enzyme Mix I, Takara RNA PCR Kit, Takara 
Biomedicals, Shiga, Japan). Real-time PCR was performed with 10 ng of cDNA and a pair of 
gene specific primers (Takara Biomedicals) added to the SYBR Premix EX Taq (Takara 
Biomedicals) and subjected to PCR amplification in the iCycler iQ Real-Time Detection 
System (Bio-Rad Laboratories, Inc., Hercules, CA, USA) (1 cycle at 95°C for 10 sec, and 50 
cycles at 95°C for 5 sec and 60°C for 34 sec). The expression of -actin was used to normalize 
cDNA levels. The PCR products were analyzed by a melting curve to ascertain the 
specificity of amplification. Data were normalized to -actin and were expressed as mean ± 
SD relative to the sham-operated non-diabetic group. 
2.8 Immunohistochemistry 
Immunostaining was performed as previously described (Faraco et al., 2007). Briefly, rats 
were sacrificed at the indicated time points and transcardially perfused with cold saline. 
Brains were fixed with 4% phosphate-buffered paraformaldehyde. Coronal brain sections (8 
m thick) were incubated sequentially with 3% hydrogen peroxide for 40 min at room 
temperature to inhibit endogenous peroxidase, followed by incubation with blocking buffer 
(100% block ace; Dainippon Sumitomo Pharma Co. Ltd., Osaka, Japan) for 2 hrs. Slides were 
incubated with polyclonal rabbit anti-IL-1 antibody (1:300, Santa Cruz Biotechnology, CA, 
USA), polyclonal rabbit anti-TNF-antibody (1:200; Rabbit mAb, Hycult Biotech, PB Uden, 
The Netherlands), polyclonal rabbit anti-COX-2 antibody (1:200, Cayman Chemical, 
Michigan, USA), polyclonal rabbit anti-iNOS antibody (1:200, Santa Cruz), monoclonal 
mouse anti-RECA-1 (1:200, Abcam Biotechnology, Cambridge, UK), polyclonal rabbit anti-
Cleaved caspase-3 (1:100, Cell Signalling Technology, Danvers, MA, USA), and monoclonal 
mouse anti-MPO (1:100, Hycult Biotech) in 0.01 mol/l phosphate-buffered saline overnight 
at 4°C. After washing with PBS, these were correspondingly incubated with Cy3- and FITC-
conjugated secondary antibodies (1:200, Chemicon, California, USA) for 2 hrs at room 
temperature. Finally, sections were incubated with the nuclear stain TO-PRO-3 (1:10000, 
Invitrogen, California, USA) in phosphate-buffered saline for 10 min at room temperature 
with gentle agitation, washed and mounted using 70% glycerol mounting medium. 
Immunofluorescence was visualized using a Laser Scanning Confocal Microscope 
(FluoView FV1000, OLYMPUS). Fluorescence intensity was quantified using imaging 
software (FV10-ASW 1.7, OLYMPUS). 
2.9 Western blotting 
The cytosolic and nuclear extracts were prepared by the method of Meldrum (Meldrum et 
al., 1997; Aragno et al., 2005). Briefly, the penumbral cortex was homogenized at 10% 
(w/v) in a polytron homogenizer (Kinematica AG, Switzerland) using a homogenization 
buffer (20 mM HEPES (pH 7.9), 1 mM MgCl2, 0.5 mM EDTA, 1% Nonidet P-40, 1 mM 
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EGTA, 1 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride, 4 g/ml pepstatin A, 
and 4 g/ml leupeptin). Homogenates were centrifuged at 1,000×g for 5 min at 4°C. 
Supernatants were removed and centrifuged at 105,000×g at 4°C for 40 min to obtain the 
cytosolic fraction. The pelleted nuclei were resuspended in extraction buffer (20 mM 
HEPES (pH 7.9), 1.5 mM MgCl2, 300 mM NaCl, 0.2 mM EDTA, 20% glycerol, 1 mM EGTA, 
1 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride, 4 g/ml pepstatin A, and 4 
g/ml leupeptin). The suspensions were incubated on ice for 30 min for high-salt 
extraction followed by centrifugation at 15,000×g for 20 min at 4°C. The samples were 
stored at -80℃ until used. Brain tissues were homogenized in the SDS sample buffer (125 
mM Tris (pH 6.8), 4% SDS, 10% sucrose, 0.01% bromophenol blue, and 10% 2-
mercaptoethanol) and boiled for 1 min. Protein concentration was quantified by using the 
Bradford method (Protein Assay Reagent Kit, Bio-Rad Laboratories). The samples (40 g) 
were separated by SDS-polyacrylamide gel electrophoresis, transferred onto a 
nitrocellulose membrane (Amersham Biosciences, Buckinghamshire, England) through a 
semidry-type blotting (Bio-Rad) method, blocked by 5% nonfat dry milk in PBS with 
Tween-20 (PBS-T) (137 mM NaCl, 8.10 mM Na2HPO4, 2.68 mM KCl, 1.47 mM KH2PO4, 
0.1% Tween-20), and incubated with appropriate antibodies as described below. The 
filters were incubated with each primary antibody overnight at 4°C, with the 
corresponding horseradish peroxidase (HRP)-conjugated secondary antibody for 1 hr at 
room temperature in 5% nonfat dry milk/PBS-T. Finally, the target molecules were 
visualized through an enhanced chemiluminescence western blotting detection system 
(Amersham Biosciences) on the X-ray film (Amersham Biosciences). The following 
primary and secondary antibodies used in this study were NF-B (rabbit, 1:2,000 Santa 
Cruz) and -actin (mouse, 1:10,000, Sigma), anti-rabbit IgG HRP antibody (1:5,000, 
Amersham Biosciences), and anti-mouse IgG HRP antibody (1:10,000, Amersham 
Biosciences).  
2.10 Statistical analysis 
Statistical analysis was performed with a two-way ANOVA followed by post hoc Tukey’s 
multiple-comparison test. Neurological deficit scores were analyzed by the Kruskal-Wallis 
test followed by the Mann-Whitney U test. In all cases a P-value of <0.05 was regarded as 
statistically significant. 
3. Results 
3.1 Physiological characteristic parameter 
The control diabetic group had typical characteristics of type 1 diabetes such as a decrease in 
the body weight (296.6 ± 33.3 g) and hyperglycemia (535.4 ± 104.0 mg/dl) compared with 
the control non-diabetic group (340.0 ± 22.4 g, 119.8 ± 17.1 mg/dl), which were similar to 
previous reports (Iwata et al., 2008; 2010). Chronic treatment of MAK for 2 weeks showed a 
slight but significant decrease in blood glucose of the diabetic rats (404.4 ± 109.2 mg/dl, 
P<0.01), whereas MAK had little effect on the body weight (266.6 ± 33.3 g). 
3.2 Infarct volume and neurological deficits after transient MCAO with reperfusion 
Figure 1 shows the effects of MAK on the brain infarction by MCAO/Re in the non-diabetic 
and diabetic groups. Representative coronal brain sections stained by TTC after MCAO/Re 
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showing viable (red) and dead (white) tissues are in (A). In the sham operated animals, 
there was no apparent damage in any brain region. The infarct area in the control non-
diabetic rats after 24 hrs of reperfusion extended to the corpus striatum and cortex, whereas 
only a small striatal infarct was observed after 3 hrs of reperfusion. In the control diabetic 
group, brain injury induced by MCAO/Re was remarkably exacerbated. The cerebral infarct 
was produced within 3 hrs of reperfusion and the infarct region was extended to a large part 
of the left striatum and cortex in the diabetic rats. In contrast, the ischemic damage in the 
MAK-pretreated non-diabetic and diabetic animal brain was smaller as compared to those 
of the respective controls. Quantitative determination of infarct volume (B) indicated that 
the cerebral infarct volume was increased and associated with reperfusion time, which was 
markedly accelerated in the control diabetic group. The infarct volume evaluated at 3 hrs 
after reperfusion in the control diabetic group was significantly increased about 5-fold as 
compared with the non-diabetic group. Brain edema also tended to be exacerbated by 
diabetes, whereas no significant difference was detected between the non-diabetic and 
diabetic groups (data not shown). Consistent with the result of brain infarct volume, 
neurological deficits were exacerbated by reperfusion and diabetes (Fig. 2). MAK-pretreated 
diabetic rats showed significant alleviation in the neurological deficits compared to the 
control diabetic rats. 
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Fig. 1. Effects of MAK on infarction induced by MCAO/Re in non-diabetic (DM) and  
DM rat brains.  
Representative coronal brain section photographs of the DM and non-DM rats stained by 
TTC at 3 or 24 hrs of reperfusion after 2 hrs MCAO (A). Infarct volume in ischemic 
hemispheres of the DM and non-DM groups after MCAO/Re by TTC staining (B). 
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Fig. 2. Effects of MAK on neurological deficits induced by MCAO/Re in non-DM and DM 
rats.  
Post-ischemic neurological deficits were evaluated at 3 or 24 hrs of reperfusion after 2 hrs of 
MCAO by a 5-point scale as described in the table. 
3.3 O2-· generation after transient MCAO with reperfusion  
Intracellular O2⁻· generation in the ischemic penumbral region of the cortex induced by 
MCAO/Re was detected using the fluorescent probe DHE (Fig. 3). O2-· generation was 
increased by diabetes and MCAO/Re. No fluorescence of DHE was detected in the cortex of 
sham operated non-diabetic rats, whereas DHE fluorescence was present in the cortex of 
sham-operated diabetic rats. MCAO and subsequent following 24 hrs of reperfusion 
induced DHE fluorescence in the ischemic region of both the non-diabetic and diabetic 
cortex, which was remarkably augmented in the diabetic brain. Pretreatment of MAK 
reduced the O2⁻· generation in the cortex enhanced by MCAO/Re and diabetes. 
 
non-DM DM
Control
24Resham
non-DM DM
(A)
MAK
100 m
0
1
2
3
4
Fl
uo
re
sc
en
ce
 o
f D
H
E 
re
la
tiv
e 
to
 
sh
am
-o
pe
ra
te
d 
no
n-
D
M
(B)
sham 24Re
aP<0.01 vs. non-DM
(n=3-4)bP<0.01 vs. DM
b
a
a
a
b
non-DM
non-DM + MAK
DM
DM + MAK
 
Fig. 3. Effects of MAK on production of superoxide after MCAO/Re in non-DM and DM rat 
brains.  
Representative photographs of superoxide production detected by DHE staining in the 
cortex coronal sections of the non-DM and DM rats (A). Quantitative analysis of DHE 
fluorescence intensity in the cortex (B). 
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3.4 Apoptosis after transient MCAO with reperfusion 
Representative histological images of TUNEL staining and cleaved caspase-3 activity in 
the control non-diabetic, MAK-pretreated non-diabetic, control diabetic and MAK-
pretreated diabetic groups subjected to MCAO and 3 or 24 of hrs reperfusion are observed 
in Figs. 4 and 5. TUNEL staining of the ischemic penumbral region of the cortex was 
performed to determine nucleosomal DNA fragmentation accompanied by apoptotic cell 
death. In sham-operated non-diabetic and diabetic rats without MCAO/Re, no TUNEL 
positive cells were detected in the brain sections. TUNEL positive cells were increased in 
both the control non-diabetic and diabetic rats especially by MCAO and 3 hrs of 
reperfusion, which was remarkably suppressed by the pretreatment of MAK. The 
activation level of caspase-3, which directly activates DNase in the apoptotic final process 
was determined by immunostaining for cleaved caspase-3 in the ischemic penumbral 
cortex of non-diabetic and diabetic rats. Similar to the result of TUNEL staining, the 
number of cells expressing cleaved caspase-3, an activated form of this enzyme, was 
remarkably increased by MCAO/Re in the control diabetic group as compared with the 
control non-diabetic group. Pretreatment of MAK significantly inhibited the caspase-3 
activation induced by MCAO/Re in these groups. 
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Fig. 4. Effects of MAK on neuronal apoptosis induced by MCAO/Re in non-DM and DM rat 
brains.  
Representative photographs of apoptotic cells detected by TUNEL staining in the cortex 
coronal sections of non-DM and DM rats (A). Quantitative analysis of TUNEL-positive cells 
index in the cortex (B). 
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Fig. 5. Effects of MAK on cleaved caspase-3 after MCAO/Re in non-DM and DM rat brains. 
Representative photographs of cleaved caspase-3 staining in the cortex coronal sections of 
non-DM and DM rats (A). Quantitative analysis of cleaved caspase-3 positive cells 
fluorescence intensity in the cortex (B). 
3.5 Expression of IL1- and TNF- in the cortex 
Figure 6 shows the effects of MAK on the expression of mRNA of IL-1 (A) and TNF- (B) 
in the non-diabetic and diabetic rat penumbral cortex after MCAO/Re. The control diabetic 
group had a 5.6-fold increase in the level of basal expression of IL-1 mRNA as compared 
with the control non-diabetic group. MCAO/Re increased the expression level of IL-1 
mRNA in the ischemic cortex of both groups, which was remarkably accelerated and 
augmented by diabetes. The expression level of IL-1 mRNA in the control diabetic group 
reached maximum in an early period of reperfusion and at 3 hrs of reperfusion was about 
10-fold higher than that of the control non-diabetic rats, which was significantly suppressed 
by pretreatment of MAK. Also, the control diabetic group had an increased level of the basal  
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Fig. 6. Effects of MAK on expression of pro-inflammatory cytokines mRNA in the 
penumbral cortex after MCAO/Re in non-DM and DM rat brains. 
The expression levels of IL-1 (A) and TNF- mRNA (B) in the non-DM and DM rat 
penumbral cortex after MCAO/Re were determined by real-time PCR analysis. 
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expression of TNF- mRNA as compared with the control non-diabetic rats. MCAO/Re 
increased the expression of TNF-mRNA, which was remarkably potentiated in the 
diabetic group. Immunohistochemistry for these cytokines confirmed an up-regulation in 
biosynthesis of IL-1 and TNF-by MCAO/Re and diabetes (Figs. 7 and 8). The expression 
of these pro-inflammatory cytokines was markedly accelerated in the ischemic diabetic rat 
cortex, whereas pretreatment of MAK significantly suppressed the augmented expression of 
both these cytokines. 
 
(A)
#2 #3non-DM
DM
Control
MAK
Control
MAK
IL-1 Merge IL-1 MergeIL-1 TO-PRO-3Merge
sham 3Re 24Re
TO-PRO-3 TO-PRO-3
100 m  
 
IL
-/
TO
-P
R
O
-3
0
0.2
0.4
0.6
0.8
1.0
+
++
++
++
**
*
*
non-DM + H2O
non-DM + MAK
DM + H2O
DM + MAK
(B)
sham 3Re 24Re
++ P<0.01 vs. non-DM
(n=3)
** P<0.01 vs. DM
+ P<0.05 vs. non-DM
* P<0.05 vs. DM  
Fig. 7. Effects of MAK on expression of IL-1 in the penumbral cortex after MCAO/Re in 
non-DM and DM rat brains. 
Representative photographs of IL-1 immunostaining (red fluorescence) and nuclei by  
TO-PRO-3 (blue fluorescence) in the cortex coronal sections of non-DM and DM rats. (A). 
Quantitative analysis of IL-1 fluorescence intensity in the cortex (B). 
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Fig. 8. Effects of MAK on expression of TNF- in the penumbral cortex after MCAO/Re in 
non-DM and DM rat brains.  
Representative photographs of TNF- immunostaining (red fluorescence) and nuclei by TO-
PRO-3 (blue fluorescence) in the cortex coronal sections of non-DM and DM rats. (A). 
Quantitative analysis of TNF- fluorescence intensity in the cortex (B). 
Diabetes-Mediated Exacerbation of Neuronal Damage  
and Inflammation After Cerebral Ischemia in Rat: Protective Effects of Water–Soluble Extract... 
 
227 
3.6 Activation of NF-B in the cortex 
The expression of pro-inflammatory cytokines and inflammatory mediators such as COX-2, 
iNOS and ICAM-1 in the cells is controlled by the transcription factor NF-B. Thus, the 
activation level of NF-B in the cortex tissue was estimated by western blotting (Fig. 9). 
Translocation of NF-B from cytosol to nucleus was not detected in the cortex tissue of 
sham-operated non-diabetic rats. In the control non-diabetic rats submitted to MCAO/Re, 
there was a significant increase in NF-B translocation. In contrast, the translocation of  
NF-B was observed even in the sham-operated diabetic rat cortex and was significantly 
enhanced by MCAO and subsequent reperfusion. Pretreatment of MAK markedly inhibited 
the activation of NF-B both in the non-diabetic and diabetic groups.  
 
 
Fig. 9. Effects of MAK on NF-B expression after MCAO/Re in non-DM and DM rat brains. 
Representative western blot of NF-B in cytoplasm and nucleus extracts from the non-DM 
and DM rat cortex (C: control, M: MAK). 
3.7 Expression of inflammatory mediators in the cortex 
Figure 10 shows the effects of MAK on MCAO/Re-induced gene expression of COX-2, 
iNOS and ICAM-1 in the non-diabetic and diabetic rat cortex. After MCAO/Re, no 
distinct increase in the expression level of COX-2, iNOS and ICAM-1 mRNA was 
observed in the control non-diabetic group, whereas the gene expression of these 
inflammatory mediators was strongly enhanced in the control diabetic group. 
Immunohistochemistry revealed that the control diabetic rats had an increased basal 
expression level of COX-2 and iNOS as compared with the control non-diabetic rats (Figs. 
11 and 12). The expression of ICAM-1 in endothelial cells, which indicates increased 
extravasation of neutrophils and macrophages/microglia into brain parenchyma, was 
determined using double immunostaining for ICAM-1 and endothelial cell antibody 
(RECA-1) (Fig. 13). The cortex of sham-operated diabetic rats had a significant up-
regulated level of ICAM-1 in endothelial cells as compared with the sham-operated non-
diabetic rats, which had no ICAM-1-like immunoreactive cells. MCAO/Re increased the 
expression of ICAM-1 both in the non-diabetic and diabetic groups, which was 
remarkably enhanced in the diabetic rats during 24 hrs of reperfusion. Pretreatment of 
MAK significantly reduced the expression of ICAM-1 both in the non-diabetic and 
diabetic rat cortex. Similarly, the MPO activity in the cortex was progressively increased 
during reperfusion, which was enhanced by diabetes and was significantly suppressed by 
pretreatment of MAK (Fig. 14). 
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Fig. 10. Effects of MAK on expression of mRNA of inflammatory mediators in the 
penumbral cortex after MCAO/Re in non-DM and DM rat brains. 
Expression levels of COX-2 (A), iNOS (B) and ICAM-1 mRNA (C) were determined by real-
time PCR analysis in the non-DM and DM rat penumbral cortex after MCAO/Re. 
Diabetes-Mediated Exacerbation of Neuronal Damage  
and Inflammation After Cerebral Ischemia in Rat: Protective Effects of Water–Soluble Extract... 
 
229 
 
 
 
#3
MAK
MAK
COX-2 Merge COX-2 MergeCOX-2 Merge
sham 3Re 24Re
(A)
non-DM
DM
TO-PRO-3 TO-PRO-3 TO-PRO-3
Control
Control
100 m  
 
 
 
 
 
C
O
X-
2/
 T
O
PR
O
3
+
*
++
*
+
+
**
0
0.2
0.4
0.6
(B)
sham 3Re 24Re
non-DM
non-DM + MAK
DM
DM + MAK
++ P<0.01 vs. non-DM
(n=3)
** P<0.01 vs. DM
+ P<0.05 vs. non-DM
* P<0.05 vs. DM  
 
Fig. 11. Effects of MAK on expression of COX-2 in the penumbral cortex after MCAO/Re in 
non-DM and DM rat brains. 
Representative photographs of COX-2 immunostaining (red fluorescence) and nuclei by TO-
PRO-3 (blue fluorescence) in the cortex coronal sections of non-DM and DM rats. (A). 
Quantitative analysis of COX-2 fluorescence intensity in the cortex (B). 
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Fig. 12. Effects of MAK on expression of iNOS in the penumbral cortex after MCAO/Re in 
non-DM and DM rat brains. 
Representative photographs of iNOS immunostaining (red fluorescence) and nuclei by  
TO-PRO-3 (blue fluorescence) in the cortex coronal sections of non-DM and DM rats. (A). 
Quantitative analysis of iNOS fluorescence intensity in the cortex (B). 
Diabetes-Mediated Exacerbation of Neuronal Damage  
and Inflammation After Cerebral Ischemia in Rat: Protective Effects of Water–Soluble Extract... 
 
231 
 
 
 
 
 
ICAM-1 RECA-1 Merge ICAM-1 RECA-1 MergeICAM-1 RECA-1 Merge
250 m
non-DM
DM
MAK
MAK
sham 3Re 24Re
(A)
Control
Control
 
 
 
 
IC
A
M
-1
/R
EC
A
-1
0 
0.4 
0.8 
1.2 
1.6 
+
+
*
*
(B)
sham 3Re 24Re
+P<0.01 vs. non-DM
(n=3)*P<0.01 vs. DM
non-DM
non-DM + MAK
DM
DM + MAK
 
 
 
Fig. 13. Effects of MAK on expression of ICAM-1 in the penumbral cortex after MCAO/Re 
in non-DM and DM rat brains. 
Representative photographs of ICAM-1 immunostaining (red fluorescence) and RECA-1 
(green fluorescence) in the cortex coronal sections of non-DM and DM rats. (A). Quantitative 
analysis of ICAM-1 fluorescence intensity in the cortex (B). 
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Fig. 14. Effects of MAK on MPO expression after MCAO/Re in non-DM and DM rat brains. 
Representative photographs of leukocytic infiltrate by MPO staining in the cortex coronal 
sections of non-DM and DM rats (A). Quantitative analysis of MPO fluorescence intensity in 
the cortex (B). 
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4. Discussion 
The present study shows that the STZ-induced diabetic state enhanced brain infarction and 
neurological dysfunction caused by transient focal ischemia and subsequent reperfusion in 
rats. Diabetes spontaneously enhanced ROS generation and expression of pro-inflammatory 
cytokines and inflammatory mediators via NF-B activation in the brain, which is 
accelerated after cerebral ischemia and subsequent reperfusion leading to neuronal 
apoptosis and inflammatory neurodegeneration. Chronic oral treatment of MAK alleviated 
the exacerbation of cerebral injury and neurological deficits in the diabetic state, which 
could be attributed to its antioxidant activity and anti-inflammatory effects.  
ROS-induced oxidative stress is considered to be involved in the pathogenesis of transient 
cerebral ischemic injury (Fiskum et al., 2004; Saito et al., 2005; Niizuma et al., 2009). In 
particular, reperfusion after a long period of vessel occlusion triggers explosive 
generation of ROS, which causes cell death by peroxidative damage of lipids, proteins and 
nucleic acids (Warner et al., 2004; Anabela et al., 2006). In addition to the early necrotic 
cell death in the ischemic core region, ROS triggers apoptosis, a delayed death of cells, in 
the ischemic penumbra (Nakka et al., 2008; Niizuma et al., 2010). Furthermore, ROS 
induces rupture of blood brain barrier through transcriptional activation of matrix 
metalloproteinase and pro-inflammatory cytokines resulting in the extension of cerebral 
infarction and exacerbation of brain edema (Cunningham et al., 2005; Zhao et al., 2006). In 
this study, we observed that exacerbation of damage in the brain of diabetic rats was 
accelerated in a time-dependent manner during the reperfusion phase. MCAO and 3 hrs 
of reperfusion in the control non-diabetic rats showed little infarction in the brain and 
moderate neurological deficits, whereas the diabetic rats subjected to MCAO and 3 hrs of 
reperfusion had a large infarction that was similar in size to that in the non-diabetic rats 
after 24 hrs of reperfusion and severe neurological deficits. Additionally, a histochemical 
study revealed that generation of O2⁻· and the occurrence of apoptosis in the ischemic 
penumbra were markedly increased in the brain of diabetic rats. A large amount of ROS 
locally generated by cerebral ischemia/reperfusion induces free radical chain reactions 
(Saito et al., 2005), which may be enhanced by increased oxidative stress in the diabetic 
state. Evidence is being accumulated that oxidative stress is enhanced by hyperglycemia 
in the diabetic state (Kusaka et al., 2004; Rizk et al., 2005; Tsuruta et al., 2010). In the 
diabetic state, “glucose toxicity” caused by augmentation of intracellular glucose 
oxidation process and nonenzymatic glycation of protein molecules leads to over 
production of ROS and damage of neurons and endothelial cells (Baynes 1991). Previous 
studies have demonstrated that the hyperglycemic condition in cerebral ischemia without 
diabetes exacerbates brain injury due to enhanced production of ROS in the brain 
(Anabela et al., 2006; Tsuruta et al., 2010). Augmented oxidative stress involving increased 
ROS generation, augmented lipid peroxidation and reduction of antioxidants has been 
indicated in the brain, kidney, pancreas and liver of STZ-induced diabetic rats 
(Muralikrishna Adibhatla et al., 2006). Actually, the occurrence of apoptosis in the 
ischemic penumbral region has been shown to be enhanced by diabetes and correlate with 
serum glucose (Li et al., 1999). Antioxidant enzymes such as catalase (CAT), superoxide 
dismutase (SOD) and glutathione peroxidase (GPx), which scavenge ROS, are considered 
to contribute to the neuronal protection against ischemia/reperfusion (Warner et al., 
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2004). Indeed, overexpression of SOD in transgenic mice has been shown to have a 
reduced infarction volume and edema after transient ischemia and reperfusion 
(Tsubokawa et al., 2007). Impairment of these antioxidant enzymes caused by 
nonenzymatic glycation is responsible for the increase of lipid peroxidation in the brain of 
diabetic animals. In a previous study, we also observed that the level of lipid peroxidation 
marker TBARS (thiobarbituric acid reactive substances) was elevated and activity of SOD, 
CAT and GPx was decreased in STZ-induced diabetic rat brain, which were reversed by 
chronic treatment of ascorbic acid (Iwata et al., 2010). Thus, the enhanced oxidative stress 
in diabetes is considered to cause functional impairment of antioxidant enzymes and the 
resulting diminution in antioxidative defense leads to further enhancement of radical 
reactions and other dysfunctions in the brain.  
Inflammatory mechanisms that are activated after cerebral ischemia play an important 
role in the pathogenesis of brain injury (Caso et al., 2007; Ridder et al., 2009). The 
transcription factor NF-B assumes a key role in many biological processes including 
cellular stress responses and regulates apoptosis and inflammation (Ridder et al., 2009). 
Activation of NF-B is crucial for the inflammatory responses leading to gene expression 
of pro-inflammatory cytokines and mediators in immunocytes (Hu et al., 2005; Ridder et 
al., 2009). In this study, we demonstrated that the diabetic rats had an increased basal 
level of the gene expression of pro-inflammatory cytokines IL-1 and TNF-, and 
inflammatory mediators COX-2 and iNOS as compared to that of non-diabetic rats. 
MCAO/Re increased the gene expression of these cytokines and enzymes, which was 
remarkably accelerated and augmented by diabetes. The result from immunoblot analysis 
of NF-B in the diabetic rat cortex confirmed that the increased production of these 
cytokines and enzymes was mediated by the enhanced activation of NF-B. Furthermore, 
we observed that the post-ischemic induction of MPO and ICAM-1, which are hallmarks 
of neutrophil and macrophage/microglia activation and extravasation, was significantly 
increased in the diabetic rat brain indicating exaggeration of inflammatory responses in 
ischemic injury. Our present data are in agreement with other studies describing the 
exacerbated inflammation in diabetic model animals (Li et al., 2004; Tsuruta et al. 2010; 
Tureyen et al., 2011). For example, a model of type-2 diabetes db/db mouse that has a point 
mutation of the leptin receptor showed increased brain damage and higher expression 
levels of IL-1, IL-6, ICAM-1, MPO and other inflammatory markers as compared with 
the db/+ control after MCAO/Re (Tureyen et al., 2011). A recent study using an 
electrochemical O2⁻· sensor has shown that experimental transient hyperglycemia 
induced by intravenous infusion of glucose increased local O2⁻· generation and 
exacerbated brain injury after ischemia and subsequent reperfusion in the rats (Tsuruta et 
al., 2010). Interestingly, high-mobility group box-1 and ICAM-1 in brain and plasma, 
which are induced in early inflammation and enhance inflammatory responses, were 
correlated with total O2⁻· generation during ischemia and reperfusion. Nevertheless, the 
hyperglycemia-induced overproduction of ROS may be mainly attributed to exacerbated 
inflammatory responses and cerebral damage after ischemia and reperfusion in diabetes.  
MAK, a nutritional supplement, is a water-soluble extract from a solid culture medium 
composed of bagasse and defatted-rice bran overgrown with G. lucidum mycelia. MAK is 
used as a health supplement and revitalizer, and a number of studies have demonstrated its 
anti-tumor (Kubo et al., 2005) and immunomodulating activities (Nakagawa et al., 1999) in 
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animals. However, the mechanistic basis and active ingredients responsible for its 
pharmacological effects have not been well defined. Previously, we showed that MAK 
inhibits the generation of O2⁻· and lipid peroxidation in a concentration dependent manner 
in vitro (Okazaki et al., 2008). Furthermore, oral administration of MAK to STZ-induced 
diabetic animals significantly reduced the blood glucose level and lipid peroxidation, and 
suppressed impairment of SOD, CAT and GPx in the brain (Iwata et al., 2008), liver and 
kidney (Okazaki et al., 2008). Collectively, MAK can act as an antioxidant in vivo and shows 
anti-diabetic effects by relieving diabetic-induced oxidative stress. We observed that the oral 
pretreatment of MAK with diabetic rats decreased the cerebral O2⁻· generation, apoptosis 
and subsequent inflammatory responses induced by MCAO/Re, which could be as a result 
of improved antioxidant status in the diabetic state. MAK had a slight effect on the elevated 
blood glucose level in the diabetic rats, confirming that the cerebroprotective effect of MAK 
could be due to its antioxidant activity. Recently, polysaccharides (Lin et al., 2010) and 
triterpenes (Dudhgaonkar et al., 2009), which are two major active constituents of G. 
lucidum, have been reported to suppress lipopolysaccharide-induced expression of 
inflammatory mediators via down-regulation of MAP kinase signaling cascade and NF-B 
activity both in vitro and in vivo, whereas the mechanism of their anti-inflammatory effects 
remains unclear. As MAK is assumed to contain similar polysaccharides and triterpenes, it 
might inhibit inflammatory responses directly via its immunomodulatory effects. There are 
a number of factors that may explain the severe symptom of brain ischemia in the diabetes. 
For example, the ischemic cerebral injury in diabetic state may be aggravated by acidosis, 
activation of aldose reductase and NAD(P)H oxidase, enhanced production of advanced 
glycation end-products, protein kinase C activation induced by excessive Ca2+ influx, etc. 
The effects of MAK on these factors and identification of its active ingredients need to be 
further investigated. 
5. Conclusion 
In this study, we demonstrated that the STZ-induced diabetic state markedly aggravated 
MCAO/reperfusion-induced neurological deficits, infarction and apoptosis in the rat brain. 
Furthermore, we elucidated that the levels of O2⁻· generation and pro-inflammatory 
cytokines (IL-1 and TNF-) and inflammatory mediators (COX-2 and iNOS) expression via 
NF-B activation were up-regulated in the diabetic cortex, which were remarkably 
enhanced during reperfusion after ischemia. Post-ischemic activation of neutrophil and 
macrophage/microglia and extravasation estimated by ICAM-1 and MPO expression were 
also enhanced by diabetes. Chronic pretreatment of MAK protected the diabetic rats against 
the exacerbation in cerebral ischemic injury and inflammatory responses. These results 
suggest that daily intake of MAK relieves the exacerbation of cerebral ischemic injury in the 
diabetic state, which may be mainly attributed to the improvement of augmented oxidative 
stress by its anti-oxidant effects. 
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